Basel, Switzerland

Nicole Buschmann

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 10.1

ph-index = 4

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: The Innovative Contributions of Nicole Buschmann

Introduction

Nicole Buschmann, a distinguished inventor based in Basel, Switzerland, has made significant strides in the pharmaceutical field. With a remarkable portfolio of 12 patents, she is recognized for her innovative solutions aimed at addressing complex medical challenges through the development of novel compounds.

Latest Patents

Among her latest patents, two noteworthy inventions stand out. The first, titled "Formylated N-heterocyclic derivatives as FGFR4 inhibitors," presents a compound formula along with its pharmaceutical applications. This invention not only describes a novel compound and its manufacturing process but also outlines its therapeutic uses, showcasing the potential for impactful treatments.

The second patent, "Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors," further demonstrates her expertise in creating therapeutic solutions. This patent also highlights the uses of specific compounds, emphasizing their significance in the pharmacological landscape.

Career Highlights

Nicole Buschmann's career has been largely associated with Novartis AG, a global leader in the pharmaceutical industry. Her dedication to innovation has played a crucial role in the company's mission to improve healthcare outcomes. Throughout her tenure, she has consistently contributed to research and development initiatives, positioning herself as a pivotal figure in her field.

Collaborations

In her quest for groundbreaking discoveries, Nicole has collaborated with talented professionals such as Pascal Furet and Robin Alec Fairhurst. These partnerships reflect her commitment to teamwork and the sharing of knowledge, both critical components in the fast-evolving world of biotechnology and pharmaceuticals.

Conclusion

Nicole Buschmann exemplifies the spirit of innovation through her impressive patent portfolio and dedication to research. Her contributions to FGFR4 inhibitor development highlight the significance of her work at Novartis AG and her collaborations with fellow researchers. As she continues to push the boundaries of medical science, Nicole serves as an inspiration for aspiring inventors and scientists worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…